Tci Wealth Advisors, Inc. Allakos Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$8.55 - $111.89 $461 - $6,042	-54 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$76.53 - $110.43 $2,066 - $2,981	27 Added 100.0%	54 $6,000
Q2 2021 Aug 02, 2021	SELL	$85.37 - $114.1 $85 - $114	-1 Reduced 3.57%	27 $2,000
Q1 2021 Apr 29, 2021	BUY	$109.73 - $153.66 $3,072 - $4,302	28 New	28 $3,000

105

77.4M

70.7K

2.8K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $64.4M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.